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Abstract
Background: Exposure to airborne particles has a major impact on global health. The probability of these particles
to deposit in the respiratory tract during breathing is essential for their toxic effects. Observations have shown that
there is a substantial variability in deposition between subjects, not only due to respiratory diseases, but also
among individuals with healthy lungs. The factors determining this variability are, however, not fully understood.
Method: In this study we experimentally investigate factors that determine individual differences in the respiratory
tract depositions of inhaled particles for healthy subjects at relaxed breathing. The study covers particles of diameters
15–5000 nm and includes 67 subjects aged 7–70 years. A comprehensive examination of lung function was performed
for all subjects. Principal component analyses and multiple regression analyses were used to explore the relationships
between subject characteristics and particle deposition.
Results: A large individual variability in respiratory tract deposition efficiency was found. Individuals with high deposition
of a certain particle size generally had high deposition for all particles <3500 nm. The individual variability was explained
by two factors: breathing pattern, and lung structural and functional properties. The most important predictors were
found to be breathing frequency and anatomical airway dead space. We also present a linear regression model
describing the deposition based on four variables: tidal volume, breathing frequency, anatomical dead space and
resistance of the respiratory system (the latter measured with impulse oscillometry).
Conclusions: To understand why some individuals are more susceptible to airborne particles we must understand,
and take into account, the individual variability in the probability of particles to deposit in the respiratory tract by
considering not only breathing patterns but also adequate measures of relevant structural and functional properties.
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space, Lung dose, Inhalation, Individual variability
* Correspondence: jenny.rissler@ri.se
1Chemistry, Materials and Surfaces, SP Technical Research Institute of
Sweden, Ideon Gateway, Sheelevägan 27, SE-223 70 Lund, Sweden
2Ergonomics and Aerosol Technology, Lund University, Box 118, SE-221 00
Lund, Sweden
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Rissler et al. Particle and Fibre Toxicology  (2017) 14:10 
DOI 10.1186/s12989-017-0190-8
Background
Exposure to airborne particulate matter impacts global
health in many ways. It has toxic effects due to urban air
pollution or indoor smoke from combustion sources; the
transmission of infectious diseases due to bacteria (e.g.,
tuberculosis) or viruses (e.g., measles or SARS); and aller-
gic diseases, where small amounts of specific substances
cause problems for groups with hypersensitivity of the im-
mune system [1, 2]. The probability of particulate matter
to deposit in the respiratory tract during breathing is es-
sential to the health effects of the particles and is also of
relevance for pulmonary drug delivery. A substantial vari-
ability in deposition between subjects has been observed,
not only among those with respiratory diseases, but also
among individuals with healthy lungs (e.g., [3–9]). The
factors determining this variability are, however, not fully
understood.
The particle deposition fraction, DF, of inhaled aerosols
varies by more than one order of magnitude – from less
than 0.1 to almost 1 – depending on breathing pattern,
structure of the respiratory tract, and particle characteristics
such as size, shape and hygroscopicity [10]. Theoretical
model calculations of DF provide valuable information
about regional deposition and deposition in different airway
generations. But models based on general assumptions are
not able to describe the full complexity of the inhalation
system, let alone all aspects of the biological variability be-
tween individuals (e.g., [11, 12]). Thus, models still need to
be validated by experimental measurements.
The available experimental data on respiratory tract
deposition of aerosol particles are fragmented and diffi-
cult to evaluate because of the lack of a common meth-
odological standard. Typically, studies are limited to less
than 10 subjects and several of the most influential only
include 2–5 healthy (male) adults (e.g., [13–18]), with
some exceptions (e.g., [19–21]). The information on pa-
rameters that determine inter-subject variability is very
limited, partly because most measurements are made for
controlled breathing over a narrow particle size interval.
Experimental data on DF for children are almost
completely lacking [20, 22, 23]. Furthermore, there are
substantial methodological uncertainties [24]. In many
studies, a medical examination of the subjects is omitted
or, if included, limited to basic lung function through
normal spirometry. Thus, DF can be related to breathing
pattern, which usually is reported, but not to the struc-
tural and functional properties of the lung. In addition,
the measurement methods are often biased by issues
such as particle losses in the mouthpiece and tubing,
pressure variations, failure to account for the increased
humidity of the exhaled air and limitations of the avail-
able detection techniques.
In this research we used a well-characterized methodo-
logy [25–27] to measure the fully size-resolved DF. In the
study we combined four experimental features: (i) a large
group of subjects (67), (ii) a broad age interval (7–70
years), (iii) size-resolved particle deposition over a wide
size range (15–5000 nm), and (iv) a comprehensive exami-
nation of pulmonary function. In so doing, we were able
to broadly explore the most important associations




The study included in total 67 non-smoking participants,
aged 7–67 years (sumarized in Table 1). Seven of the
participants were 7–12 years old, while there were no
participants in the interval 12–20 years. Excluding sub-
jects in this age interval was motivated by the rapid de-
velopment of the lungs that occurs sometime during this
age with a high intra-individual variability. All subjects
were subjectively healthy and no subject reported any
history of disease that was expected to affect lung func-
tion or aerosol deposition. No subject reported a smok-
ing history >1 pack a year, and all subjects were required
to have lung function measurements within the normal
ranges. The study was reviewed and approved by the re-
gional ethics committee in Lund, Sweden, (dnr 2009/465)
in accordance with the Declaration of Helsinki. All partici-
pants gave their written informed consent.
The size-dependent respiratory tract deposition pat-
tern of hydrophobic particles was measured during
spontaneous breathing through a mouthpiece, while sit-
ting in a relaxed position. For each participant a com-
prehensive lung function investigation was performed.
The particle respiratory tract deposition and lung func-
tion were measured on two separate occasions.
Lung function measurements
Each subject went through comprehensive pulmonary
function measurements. The parameters determined in
the lung function tests are listed and described in more
detail in the Additional file 1. Vital capacity (VC), forced
expiratory volume in 1 s (FEV1), total lung capacity (TLC),
residual volume (RV), functional residual capacity (FRC),
and diffusing capacity for CO (DL,CO) were measured ac-
cording to current guidelines [28–30] using Masterscreen
Body, Viasys GmbH - Erich Jaeger, Hoechberg, Germany.
Lung mechanics variables (Fres, AX, R5, R20, etc.) were
studied with impulse oscillometry (IOS, Viasys GmbH -
Erich Jaeger [31]). Respiratory dead space (VDaw) was mea-
sured by a single breath wash-out of CO2 (MasterScreen
Capno, Viasys GmbH - Erich Jaeger) and delineated ac-
cording to Wolff, Brunner [32].
In Tables 1 and 2, selected lung function data are pre-
sented together with percent of predicted lung function.
The selection of the variables included in the primary
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statistical analysis was based on the assumed relevance
for respiratory tract deposition. Variables reflecting the
structure and mechanics of the lungs were thus included
rather than variables reflecting gas exchange over the
alveolar-capillary barrier.
Particle deposition fraction measurements
The measurements were performed for spontaneous
mouth breathing wearing a nose clip. As pointed out in
earlier studies ([19] and references therein) this can, for
some individuals, result in higher tidal volumes compared
to natural relaxed breathing. In this study we observe
higher tidal volumes and longer breath cycles than ex-
pected for fully natural breathing [33], but not far from
(slightly higher) the default variables used in the multiple
path particle dosimetry model (MPPD [34]). A shift in
breathing pattern should not affect the conclusions on the
factors that determine particle deposition. Lung function
variables that are affected by body position and mouth-
piece position, such as airway dead space, were measured
with subjects sitting, as they were during the deposition
measurements.
The deposition measurements began with a short test
period (5 min.) during which the subjects became fa-
miliarized with the equipment. Thereafter, the
deposition patterns were measured during two periods
of 12 min each. To ensure complete mixing in the
lungs and in the instrument, the first minute of meas-
urement was discarded. The breathing patterns were
recorded during the measurements and converted into
BTPS (body temperature and pressure, saturated). The
parameters VT (tidal volume), Tbc (time of a breath
cycle) and VE (minute volume ventilation rate) pre-
sented in Table 1 were recorded during the respiratory
tract deposition measurements.
The set-up used for the respiratory tract deposition mea-
surements was a further development of a methodology
used and described in several previous studies [24–26].
The main instrumental improvement compared to the pre-
vious studies was the extension of the particle size range
measured, from 10 nm to 500 nm in the original instru-
ment, to cover diameters up to 5 μm in the present study.
In order to include large particles (>0.5 μm), several in-
strumental modifications were made. The main changes
were: i) adding an Aerodynamic Particle Sizer (APS,
model 3321, TSI®) for on-line characterization of parti-
cles with equivalent aerodynamic diameters from 700
to 5000 nm, and ii) redesigning the set-up to minimize
particle losses in the apparatus from inertial impaction
and gravitational settling as these deposition
Table 1 Overview of the individuals recruited for the study, lung function, and breathing parameters
Age (y) Males Females Height (cm) Weight (kg) VT (L) Tbc (min) VE (L/min) VDaw (L) R5 (kPa · s/L) R20 (kPa · s/L)
7–12 7 142 (±14) 40 (±13) 0.51 (±0.13) 0.063 (±0.011) 8.1 (±0.9) 0.098 (±0.030) 0.66 (±0.17) 0.49 (±0.09)
20–29 6 13 170 (±8) 64 (±12) 0.73 (±0.22) 0.100 (±0.042) 7.6 (±1.3) 0.155 (±0.045) 0.33 (±0.08) 0.31 (±0.06)
30–39 6 7 177 (±11) 73 (±13) 0.77 (±0.29) 0.102 (±0.035) 7.5 (±0.9) 0.177 (±0.079) 0.35 (±0.06) 0.33 (±0.08)
40–49 3 3 174 (±8) 73 (±13) 0.71 (±0.18) 0.085 (±0.023) 8.5 (±1.3) 0.203 (±0.065) 0.32 (±0.12) 0.30 (±0.13)
50–59 5 7 173 (±8) 82 (±13) 0.79 (±0.22) 0.104 (±0.035) 7.8 (±1.2) 0.175 (±0.053) 0.35 (±0.11) 0.29 (±0.08)
60–70 5 5 171 (±8) 79 (±11) 0.73 (±0.14) 0.103 (±0.019) 7.2 (±1.2) 0.236 (±0.065) 0.33 (±0.10) 0.25 (±0.07)
Ad. av. 25 35 173 (±9) 73 (±14) 0.75 (±0.22) 0.100 (±0.034) 7.6 (±1.2) 0.183 (±0.065) 0.34 (±0.09) 0.30 (±0.08)
Values in parentheses correspond to one standard deviation. The parameters VT = tidal volume; Tbc = time of a breath cycle; VE = minute volume ventilation rate
are values recorded during the deposition measurements. VDaw corresponds to anatomical airway dead space and R5 and R20 to the resistance of the respiratory
system measured with impulse oscillometry at 5 Hz and 20 Hz, respectively
Table 2 Measured average lung function
% of Predicted
Age (y) TLC (L) FRC (L) FEV1 (L) VC (L) RV (L) FEV1/VC TLC (L) FRC (L) FEV1 (L) VC (L) RV (L) FEV1/VC
7–12 3.5 (±0.6) 1.5 (±0.3) 1.9 (±0.6) 2.4 (±0.6) 0.95 (±0.2) 75.2 (±9.6) 106 (±9) 106 (±34) 95 (±17) 103 (±9) 119 (±27) 91 (±11)
20–29 6.3 (±1.0) 3.2 (±0.7) 3.9 (±0.6) 4.5 (±0.6) 1.6 (±0.4) 83.6 (±4.1) 108 (±9) 108 (±16) 104 (±9) 105 (±8) 109 (±23) 100 (±5)
30–39 7.3 (±1.5) 3.6 (±0.8) 4.1 (±1.1) 5.0 (±1.3) 1.9 (±0.3) 77.2 (±5.8) 113 (±8) 113 (±18) 107 (±11) 110 (±8) 107 (±21) 94 (±7)
40–49 7.2 (±1.1) 3.8 (±1.0) 3.7 (±0.6) 4.7 (±0.7) 2.3 (±0.5) 76.3 (±7.9) 115 (±14) 119 (±26) 108 (±7) 114 (±13) 119 (±28) 95 (±10)
50–59 6.7 (±1.3) 3.3 (±1.2) 3.2 (±0.5) 4.1 (±0.9) 2.3 (±0.5) 73.5 (±5.0) 110 (±14) 103 (±28) 104 (±12) 109 (±13) 112 (±19) 94 (±6)
60–70 6.3 (±1.1) 3.2 (±0.7) 2.8 (±0.7) 3.7 (±0.9) 2.3 (±0.3) 70.2 (±4.4) 104 (±10) 100 (±14) 101 (±17) 107 (±18) 104 (±11) 92 (±5)
Ad. av. 6.7 (±1.3) 3.4 (±0.9) 3.6 (±0.9) 4.7 (±1.1) 2.0 (±0.5) 77.2 (±7.0) 110 (±11) 108 (±20) 105 (±11) 108 (±12) 109 (±20) 96 (±7)
Values in parentheses correspond to one standard deviation
TLC total lung capacity, FRC functional residual capacity, FEV1 forced expiratory volume in 1 s, RV residual volume, VC vital capacity
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mechanisms are increasingly important for particles lar-
ger than 1 μm. The upper size limit was set by the par-
ticle losses in the set-up.
During the measurement, the inhaled and exhaled par-
ticles were sampled and characterized with two on-line
instruments measuring the particle number size distri-
bution: a Scanning Mobility Particle Sizer (SMPS) and
an APS. The paths of the aerosol from the inhalation
and exhalation tank to the SMPS or APS were designed
to minimize particles losses, and were made as symmet-
ric as possible to get similar losses in the flow lines when
sampling from the inahlation tank or exhalation tank,
illustrated in Additional file 1: Figure S2. From the
difference in the inhaled and exhaled particle number
size distributions, the particle size-resolved deposition
fraction (DF) was determined. All the critical factors
(e.g., total instrumental particle losses, mouthpiece dead
space, heating to avoid condensation) for accurate res-
piratory tract deposition fraction measurements pointed
out in a previous critical review were considered [24]. The
new system is described in more detail elsewhere [27].
The SMPS classifies the particles according to their
mobility diameter, equivalent to the thermodynamic
diameter. In the set-up, the SMPS covers the size range
of 15–500 nm. The mobility diameter (dme) is the
equivalent diameter that has been proved to determine
the respiratory tract deposition of particles of diameters
<300 nm [26], explained by the fact that diffusion is the
dominating deposition mechanism for these particles.
Deposition by diffusion is governed by the particle diffu-
sivity (Brownian motion) and is related to the mobility
diameter as 1/dme [35]. The APS classfies particles ac-
cording to their aerodynamic particle diameter (dae). In
this system, the APS covers the diameter range ~700 nm
to 5000 nm. The aerodynamic size is the most appropri-
ate equivalent size determining the lung deposition of
particles >500 nm, for which the main deposition mech-
anisms are impaction and gravitational settling.
The aerosol generated for the study consisted of
hydrophobic particles in order to avoid particle hygro-
scopic growth in the lungs. To cover the whole particle
size range (15–5000 nm), two different particles types
were used: carnauba wax (in the size range of 15–
500 nm), and manufactured spherical glass particles (in
the range 500–5000 nm). The carnauba wax aerosol
particles were generated by an in-house built evaporation-
condensation generator and the glass particles were de-
agglomerated and dispersed into air by a Vilnius Aerosol
Generator (VAG, CH Technologies, Inc., Westwood, NJ).
Details about the particle generation and size distributions
are given elsewhere [27]. Due to the minima in the particle
concentrations in the size range 350–700 nm, the steep
slopes of the distributions, and the low counting efficiency
of the APS for particles with a diameter below about
800 nm, the deposition data in the interval from 350 to
800 nm contained large uncertainties and were excluded.
Furthermore, the respiratory tract deposition fraction was
low in this size interval and thus only resulted in weak
correlations in the statistical analysis and, accordingly, did
not contribute further to the understanding of the indi-
vidual variability in respiratory tract deposition.
Statistical analysis
SPSS (IBM©SPSS© Statistics, v 23) was used for statis-
tical analysis. To select a sub-set of relevant variables
from the original data set, a factor analysis (principal
component analysis, PCA) was performed. A PCA is a
technique to reveal the interrelations between a set of
variables and can be used to reduce the number of di-
mensions in the data. The PCA is here used to identify
correlations among the independent variables. An out-
come of the PCA is a number of components describing
the variability in the data and the corresponding loadings
(equivalent to standardized regression coefficients). The
loadings represent the correlations between the variables
and component. The variables investigated in the suc-
ceeding stepwise linear multivariate regression analysis
were selected based on the PCA and a bivariate (Pearson’s)
correlation analysis, together with knowledge about the
variables and the particle deposition mechanisms. The sig-
nificances presented are those at the 0.05 or 0.01 levels.
The multivariate regression analysis was first per-
formed with the data set including only the adults. A
second analysis followed including all subjects. The cor-
relations between the lung function and breathing pa-
rameters with the size-dependent deposition fraction
were evaluated by pooling deposition fractions in ten
size intervals (logarithmic intervals from the measured
size bins [4–5 bins per interval] of the SMPS and APS):
15–30, 30–50, 50–100, 100–200, 200–350, 850–1300,
1300–1900, 1900–2700, 2700–3500, and 3500–5000 nm.
Due to the lower number concentrations and the steep
slopes in the distributions in the size range 200 to
1300 nm, together with instrumental limitations, the most
reliable intervals were considered to be the four lowest
(covering 15–200 nm) as well as the four intervals in the
size range 1300–5000 nm (see Tables 3 and 4).
Results
The average size-resolved deposition fraction found is
shown in Fig. 1 for the group of adults (20–70 years)
and for the children (7–12 years). The DF of the chil-
dren is higher than for adults by on average 11%, but the
difference is not statistically significant. Other age-
dependent differences in DF within the adult group, as
well as gender differences, are smaller than this and not
significant (further discussed in the method paper [27]).
For each individual, the deposition fraction for particles
Rissler et al. Particle and Fibre Toxicology  (2017) 14:10 Page 4 of 12
of a certain size correlate with the deposition fraction
for particles of other sizes, that is, for particles with a
diameter <3500 nm, as illustrated in the correlation plot
in Fig. 2. Thus, individuals with a high deposition of a
certain particle size tend to have a high deposition for all
particles, up to 3500 nm. Typical Pearson’s correlation
coefficients between the individually paired DFs of
different size intervals are ~0.8–0.9. The correlations
between paired DFs for particles in the size interval
>3500 nm with particles <3500 are less, with Pearson’s
correlation coefficients of ~0.5.
Statistical evaluation and multivariate linear regression
model
Several of the independent variables correlate with the
dependent variable, DF (right part of Table 3). This is
because several of the independent variables themselves
are correlated. In Additional file 1 an overview of the
correlation (bivariate) between the independent variables
is given (Table S1). A common spirometric indicator of
respiratory disease is FEV1. Only a few studies have in-
vestigated relationships between FEV1 and DF in healthy
subjects and none of these found a correlation [36–38].
Table 3 Results from the PCA, the bivariate regression analysis, and some descriptive statistics (adults)
Columns 1–4 show the results of the PCA (varimax-rotated component matrix) with PC loadings/coefficients. Color indicates the component to which each
variable was mostly associated. The orange coloring of R5 indicates that this variable is equally associated to components 2 (red) and 3 (yellow). The loadings/
coefficients are a measure of the correlation between the variable and the component. These columns are followed by descriptive statistics and Pearson’s
coefficients from the bivariate statistical analysis of correlations between the independent variables and deposition fraction (DF). 0.05 and 0.01 significance levels
are indicated by a grey background and by * and **, respectively
Table 4 Results from the multiple regression model of DF, based on adults only
Unstandardized coefficients Standardized coefficients
Size intervals Const. Tbc [min] VDaw [L] R5 sss [kPa · s · L
−1] VT [L] Tbc VDaw R5 VT R
15–30 0.60 1.07* −0.76* 0.10** 0.14* 0.37 −0.50 0.09 0.33 0.835
30–50 0.37 1.15* −0.67* 0.30* 0.18* 0.34 −0.38 0.23 0.35 0.824
50–100 0.19 1.69* −0.38* 0.29* 0.09 0.51 −0.22 0.23 0.17 0.774
100–200 0.22 1.19* −0.51* 0.10 0.04 0.46 −0.38 0.10 0.09 0.677
200–350 0.17 0.94* −0.30* 0.07 0.03 0.94 −0.30 0.07 0.03 0.642
850–1250 0.19 2.47* −0.23* 0.10 −0.05 0.81 −0.14 0.08 −0.11 0.750
1300–1900 0.23 2.29* −0.28* 0.18** 0.05 0.67 −0.16 0.14 0.10 0.815
1900–2700 0.40 1.63* −0.62* 0.15** 0.15 0.49 −0.34 0.11 0.29 0.830
2700–3500 0.52 0.98* −0.40* 0.19** 0.15** 0.37 −0.28 0.19 0.36 0.798
3500–5000 0.62 (0.70) 0.43* (0.34) 0.30 0.29** (0.20) 0.04 (0.07) 0.20 (0.16) 0.25 0.34 (0.24) 0.12 (0.20) 0.496
The multiple regressions include the variables Tbc (time of a breath cycle), VDaw (anatomical dead space), R5 (airway resistance at 5 Hz), and VT (tidal volume). R is
the multiple correlation coefficient
For the largest particles, the analysis was made with and without VDaw (latter value in parentheses). Standardized coefficients give an indication of the effect of
each independent variable on the dependent variable (standardizing the variables before running the regression results in all variables being on the same scale)
Significance on a 0.05 level is indicated by*
Significance on the same level (0.05) when also including the children is indicated by**
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A significant association, however, was found in two
studies including patients with COPD [36, 39]. In this
study, we see no correlation with FEV1, as expected for a
healthy group with normal spirometry at relaxed breath-
ing for particles <5000 nm.
In order to reduce the number of variables, an ex-
ploratory factor analysis (PCA, varimax-rotated solution)
was performed on the data set containing the adults.
The PCA results suggest that four components explain
the observed correlation among the independent variables.
The corresponding loading/coefficient of each variable
in each component is presented in Table 3 (adults). The
table also provides the bivariate Pearson’s correlation
coefficients (with significance levels of 0.01 and 0.05 in-
dicated) between the size-dependent particle deposition
fractions and the variables, as well as some descriptive
statistics (average values and standard deviations).
The selection of variables used in the stepwise multi-
variate linear regression was based on the PCA and the
bivariate correlation analysis, along with the understand-
ing of the variables and the physical deposition mecha-
nisms. The main variables selected to explore the
deposition of particles in the respiratory tract were VC
(representing principal component 1, PC1), VDaw (PC2),
R5 (representing both PC2 and PC3), Fres (PC3), and Tbc
(C4). Other variables explored were height, VE, TLC (all
representing PC1), RV, FRC, R20 (all representing PC2),
AX (PC3) and VT (PC4). More details of the variables
are found in section S1 in Additional file 1.
According to the statistical analysis, the variables that
best predict the deposition fraction are those belonging
to principal components 2 and 4. Component 2 includes
variables related to lung-intrinsic properties while com-
ponent 4 includes variables related to breathing pattern.
According to the stepwise multivariate linear regression
analysis, these two components have significant effects
on DF (p < 0.05) in most size intervals, except for the
largest particles (>3500 nm). Variables associated with
component 1 such as height, TLC, and VC did not result
in significant improvement of the multivariate regression
model, even if these variables partly correlate with vari-
ables in the other components and thus with DF. Com-
ponent 3 did result in significant improvement of the
model for some particle size intervals.
The breathing pattern is described by the two variables
that were mainly associated with principal component 4:
Tbc (time of a breath cycle) and VT (tidal volume). The
stepwise multivariate linear regression analysis shows
that Tbc often better explains the deposition pattern than
VT, but that VT becomes significant, in addition to Tbc,
when looking at the deposition of the smallest particles
(15–50 nm) and, when including children, also for parti-
cles >2700 nm. Even if it is not significant in all size in-
tervals, including VT as a variable in a multiple
regression analysis consistently improves the correlation
between the predicted and measured DF in all particle
size intervals.
From the stepwise multivariate analysis, it is clear that
more variables than those related to the breathing pat-
tern (Tbc and VT) are needed to predict the inter-subject
variability, especially when including the children in the
analysis. For particles <3500 nm, the anatomical airway
dead space (VDaw) is the variable related to lung-
intrinsic properties that have the strongest level of ex-
planation for the observed individual variation in DF:
the larger the VDaw, the lower the DF. The anatomical
Fig. 1 The average lung deposition fraction for adults (solid black)
and children (dashed red). Error bars correspond to one standard
deviation and reflect the inter-subject variation
Fig. 2 Paired DF of particles 30–50 nm with 1900–2700 or
3500–5000 nm particles. The figure illustrates that the DF of
small particles correlates with the DF of larger particles up to a
diameter of ~3500 nm
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airway dead space of the respiratory tract is composed of
the portion of the airways that conducts gas to the
alveoli. When excluding VDaw from the analysis, FRC be-
comes significant, representing component 2. However,
FRC does not explain the variation in DF to the same
extent as VDaw, with the exception of large particles
(1300–3500 nm) when looking at the whole group
(including the children) for which FRC and VDaw re-
sulted in the same level of explanation.
Apart from the variables associated with component 2,
airway resistance (partly associated with component 2
and partly with 3) measured with impulse oscillometry
(IOS) was also investigated, and results in significant im-
provements to modelled DF for some particle sizes. The
best correlation was achieved for the resistance mea-
sured at 5 Hz (R5). Including R5 in the multivariate re-
gression analysis improved the model for all size
intervals, but was significant only for 30–100 nm parti-
cles in the adult group. When including the children, R5
became significant in most size intervals.
Based on the results from the stepwise multiple re-
gression analysis, a linear multiple regression analysis
was performed including the variables Tbc, VT, VDaw and
R5 for DF in all particle size intervals. The resulting
coefficients (unstandardized and standardized) are pre-
sented in Table 4. The unstandardized coefficients were
used to generate the correlation plots in Fig. 3. Stan-
dardized coefficients provide an indication of the effect
of each independent variable on DF, regardless of units
(in contrast to the unstandardized coefficients). As can
be observed from the standardized coefficients in Table 4,
the variable explaining most of the variability in DF, for
most size intervals, was Tbc; however, the airway dead
space (VDaw) was nearly as important. In the analysis,
only adults were included; however, the model also ap-
plied relatively well to children, as illustrated in Fig. 3.
Excluding the children from the main analysis was done
to avoid effects related to differences only between the
two groups (adults and children). To illustrate the in-
fluence of lung morphology on DF, the predicted DF
based on a multiple regression model including only
Tbc and VDaw is also shown in Fig. 3. A similar analysis
including all subjects (i.e., adults and children) is pre-
sented in Additional file 1: Table S2.
For particles >3500 nm, the significant correlation
between DF and airway dead space disappears, while the
significant correlation between DF and Tbc remains. R5
is significant when including the data set of the children.
However, replacing R5 with R20 in this size interval re-
sults in a slightly stronger correlation with DF, which is
not the case for DF of the smaller particles.
Discussion
Overall, in the sub-micrometer particle size range the
measured deposition fractions reported in this study
Fig. 3 Results from the multiple regression analysis. The analysis included only adults (blue multiplication sign). The DF of children was also
predicted (red plus sign) using the parameters resulting from the regression model for the adult group. To illustrate the influence of lung morphology
on the DF of children, the same analysis as above was performed but only including VT and Tbc as variables (°)
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are in agreement with previous studies where respira-
tory tract deposition has been measured for healthy
subjects during spontaneous breathing of hydrophobic
particles [4, 6, 9, 19, 26, 37, 39–41]. For particles larger
than 1 μm, the DF values obtained are 0.2–0.3 higher
than previously reported in two studies by Heyder et al.
and Bennett et al. [6, 19], but lower than those mea-
sured by Montoya et al. [42] for ambient aerosols and
in a similar range as the data reported by Giacomelli-
Maltoni, Melandri [43] and Chan, Lippmann [3]. The
DFs measured are not fully intercomparable since
the breathing patterns and lung physiology of the
subjects differ. This is further discussed in the
method-paper [27].
Individuals with a high deposition of a certain particle
size had a high deposition for all particles, up to
3500 nm. That is despite the fact that the deposition of
particles with different sizes is governed by different
mechanisms: typically diffusion for particles <500 nm,
sedimentation for particles >500 nm, and impaction for
particles >2 μm (diameters given are rough estimates
and depends on flow and tube dimensions). In the per-
ipheral airways, the dominating deposition mechanisms
are diffusion and sedimentation (or gravitational set-
tling). Diffusion and sedimentation are affected in a
similar way by i) flow, ii) residence time, and iii) di-
mensions of the airways. These facts likely explain the
high correlation between paired DFs of different sizes
of particles <3500 nm. In the upper and more central
parts of the lungs, where the air velocity is higher, iner-
tial impaction plays a more important role. Thus, im-
paction is governed by other lung-intrinsic properties
than sedimentation and diffusion. Contrary to diffusion
and sedimentation, impaction increases with increasing
flow rates. The decrease in the paired correlation
between the DF for particles >3500 nm implies that
impaction becomes more dominant for particles in this
size interval, even at the low flow rates during normal
relaxed breathing.
Breathing variables (PC 4)
The correlation between DF and Tbc is explained by dif-
fusion and sedimentation being deposition mechanisms
both of which depend on the particle residence time.
This has been reported earlier. Heyder et al. [44, 45]
state that for both diffusion and sedimentation, the
number of particles deposited in the airway dead space
is negligible compared to the number deposited in the
peripheral airways (for particles <2 μm). Consistent with
this, Rudolf et al. [6, 17, 46] suggest that the pulmonary
DF is explained to a large extent by: (i) the residence
time of the air in the alveoli, and (ii) the fraction of the
tidal volume that reaches the alveolar region (VTA/VT).
These two factors were investigated by Shiller et al. [17]
by altering the tidal volume in a homogeneous group of
male adults (n = 4).
Our observations from the statistical analysis of the
relative influence of VT and Tbc are in line with Bennet
et al.’s [19], who found that breathing frequency (∝1/Tbc)
best predicts the DF. They are also in line with the ob-
servations of Schiller et al. [17], who reported that for
the smallest particles, VT becomes more important for
describing the variability in DF. Kim and Jaques [7]
concluded that Tbc and VT are equally influential on de-
position for the submicron particles in the size interval
40–100 nm, while in our study the size interval was
somewhat lower, 15–50 nm. For particles in the range
2700–3500 nm, though, VT and Tbc are also equally in-
fluential. This is the size interval where deposition by
sedimentation in the peripheral airways is expected to
peak (at normal breathing).
For a flow-through system, such as a tube, the resi-
dence time is linearly proportional to the flow rate.
However, a flow-through system is not representative for
particles deposited in the peripheral lung, and accordingly
the multivariate regression analysis shows that it is Tbc
and VT that determine the deposition rather than the mi-
nute volume ventilation rate (VE). This has been reported
in several previous studies (e.g., [7, 19, 47]). For particles
deposited by impaction in the upper and central parts of
the lungs, the deposition more resembles that in a flow-
through system, and the deposition fraction is expected to
be flow dependent.
Airway anatomy (PC 2)
Our data shows that there is a clear correlation between
not only to the breathing variables associated with PC4
but also between some of the intrinsic properties of the
lungs associated with PC2. In the descriptive model sug-
gested by Kim et al. [7], only variables describing the
breathing pattern was included and no lung-intrinsic
properties. The study was performed on young healthy
subjects following a predetermined breathing pattern
with particles in the 40–100 nm range. When applying
their model to the breathing parameters of the subjects
of our study, it became evident that more variables were
needed to explain the observed inter-subject variability
in DF. The study by Kim et al., similar to many previous
studies, measured the deposition fraction for a relatively
homogeneous group of young healthy adults. This likely
explains why in the present study, in contrast to Kim et
al., we found that lung-intrinsic properties are needed to
explain the individual variability in DF. This was also
noted by Finlay and Martin [48] who further developed
the equations suggested by Kim et al. to include FRC.
Bennett et al. [19] studied the DF during controlled
spontaneous breathing for a large group of people in a
wide age span (18–80 years), using a monodisperse
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aerosol of 2 μm particles (optical equivalent diameter).
They also found that the intra-subject correlations in the
DF were explained by the intrinsic characteristics of the
individuals, such as lung morphology. That study
showed that apart from the breathing variables, the spe-
cific airway resistance (measured by body plethysmogra-
phy) together with effective airspace diameter (EAD),
were the best predictors of DF. EAD is a measure of the
size of the airways, measured by the deposition of air-
borne particles during a breath hold, according to the
principle described by Heyder [49]. VDaw was not mea-
sured. We used spontaneous breathing in our study. The
effects of lung morphology could have been better iso-
lated using a controlled breathing pattern, which, on the
other hand, would not fully reflect spontaneous
breathing.
The airway dead space, VDaw, is the variable related to
the lung-intrinsic properties that best describe DF: the
smaller the VDaw, the higher the DF. VDaw represents the
anatomical dead space of the respiratory tract and is
composed of the conducting airways (i.e., the portion of
the airways that conducts gas to the alveoli from the
mouth down to the respiratory bronchioles). About half
of the VDaw is in the distal airways, below generation 10
[50]. When removing VDaw from the stepwise multiple
regression analysis, FRC steps in and becomes significant.
FRC and VDaw are correlated since a small part of the FRC
is composed of VDaw,, and possibly also since they both
may reflect the general size of the respiratory tract.
In a few previous studies (e.g., [34, 48, 51]), FRC
was used to account for some aspects of respiratory
tract geometry. Finlay and Martin [48] proposed that
further variability in DF can be explained by differ-
ences in the conducting airways. Also in the early
studies by Rudolf et al. [17, 45, 46], VDaw was sug-
gested as a variable explaining DF.
The correlation between DF and airway dead space
could at first be misinterpreted as a small dead space
(and thus smaller dimensions of the airways) leading to
higher deposition in the conducting airways. Drawing
the parallel to particle losses in a tube, the losses by dif-
fusion and sedimentation would increase with decreas-
ing radial dimensions of the tube – if the air velocity
was kept constant. However, if the air volume flow is
kept constant when decreasing the dead space (and thus
tube radius), the air velocity would increase, possibly
leading to shorter residence times and lower deposition.
To further investigate this, calculations were made of
particle losses by diffusion and sedimentation in a hori-
zontal tube. More details about these calculations are
found in section S3 in Additional file 1. The calculations
were performed assuming both laminar and turbulent
flow and show that reducing the radius of a tube results
in lower, or similar, particle depositions. Thus, the
observed effect of increasing DF with decreasing VDaw
cannot be explained by increased deposition in the con-
ducting airways.
As mentioned in the discussion regarding VT, the
studies by Rudolf et al. suggest that the deposition is partly
determined by the fraction of the tidal volume that
reaches the lung periphery (VTA/VT), which may be also
be expressed as a function of VDaw as 1-VDaw/VT. Thus, a
smaller airway dead space results in a larger fraction of VT
entering the lung periphery, which may increase the par-
ticle deposition there. This is consistent with our observa-
tions of decreasing DF with increasing VDaw.
In addition, the average residence time in the lung
periphery, TA, is also proportional to VDaw (with a large
VDaw, the TA becomes shorter). If making the simple
assumption of a constant flow rate (square wave
breathing pattern), TA can be expressed as (Tbc-TDaw)/2
(where TDaw is the total time the air spends in VDaw), or
(Tbc-VDaw/VE)/2 (where VE = VT/Tbc). Thus, a large VDaw
leads to a shorter TA, which in turn results in a lower de-
position by diffusion and sedimentation in the lung peri-
phery. This is also consistent with our observations..
Another possible parameter affecting the particle de-
position in the peripheral airways is the dimensions of
the peripheral airspaces [49]. In healthy subjects, one as-
sumption is that the alveolar distances are reflected by
the alveolar volume (VA). We know this is not true for
people with lung disease (e.g., pulmonary emphysema
resulting in structural changes in the alveoli). At the be-
ginning of a breath, VA can be estimated as FRC-VDaw.
To evaluate the variables TA, VA and, VTA/VT, these
were added in the stepwise multiple linear regression
analysis. The analysis was carried out both for the adult
group separately, and for the whole group including the
children. For both groups, and for all sizes except the
smallest and the largest size fraction, the best predictors
were TA and VA, replacing VDaw and Tbc in the stepwise
multiple regression analysis. However, the improvement
in the correlation coefficient compared to using the ori-
ginal variables was minor. Also for the smallest particles
(15-30 nm) TA and VA were significant, but VTA/VT was
stepping in with an even higher level of explanation,
while for particles >2.7 μm only R5 was significant. In
the new analysis R5 was no longer significant for the
smaller particles, as it was in the previous analysis when
looking at the whole group.
The correlation between DF and R5 is not straight
forward to interpret. R5 is considered to reflect the total
resistance of the respiratory system, whereas the resist-
ance calculated at higher frequencies is considered to re-
flect proximal airways [52] (see Additional file 1). In
healthy subjects, as in this study, the resistance of the re-
spiratory system is low. The diameter of the airways is
inversely related to their resistance, and the association
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between DF and R5 could therefore be a reflection of
individual differences in airway dimensions in healthy
subjects. The fact that R5 showed a closer correlation to
DF than to R20 may indicate that the properties of the
small airways have a larger impact on deposition than
those of larger airways. We did not, however, find any
correlation between DF and the difference between R5
and R20, which is often considered to reflect the resist-
ance of small airways. In normal subjects, the difference
between R5 and R20 is very small [52], and there may be
too much noise in the data to see such correlation.
Nonetheless, the relationship between resistance and DF
must be interpreted cautiously. From the PCA, it ap-
pears that FRC also captures a part of PC3, and re-
placing R5 with FRC in the multiple regression analysis
did result in nearly as high correlations.
Thus, we found that the variables reflecting the di-
mensions of the lower respiratory tract explain most of
the individual variability in DF for particles <3500 nm,
consistent with diffusion and sedimentation predomin-
antly occurring in the peripheral airways. This was not
the case for particles >3500 nm and the results indicate
that impaction comes into account and thus, that DF for
this size fraction is determined also by other lung-
intrinsic properties than DF for particles <3500 nm.
These conclusions hold for healthy subjects. For subjects
with diseases resulting in structural changes or altered
breathing patterns, other lung function variables may
better reflect the particle lung deposition.
Particle deposition in the airways of children
Exposure to airborne particles may pose different risks
to different sub-populations, and children have been
identified as one of the most sensitive groups. Efforts
have been made to understand age-dependent deposition
in the lungs of children (e.g., [20, 22, 51, 53]). Some of
these studies have reported that one difficulty in doing
so is the lack of adequate information on lung geometry
during growth.
The DF for children during spontaneous breathing
has not previously been investigated together with
comprehensive pulmonary function measurements. It
should, however, be pointed out that this study only
includes 7 children. We obtain a slightly higher DF in
children than for adults (11%), but the difference was
not significant. Schiller-Scotland et al. [23] found that
the DF for the children was 50% higher compared to
adults, while Bennett, Zeman [54] did not see any
significant difference. Bennett and Zeman explained
the large difference between the two groups observed
by Shiller-Scotland et al. as an effect of the mouthpiece,
resulting in children increasing their tidal volume com-
pared to normal relaxed breathing. The set-up may also
affect breathing pattern due to the resistance of the
instrument and thus, different set-ups can affect breathing
pattern differently.
The difference in the deposition rate (deposited parti-
cles per time unit, i.e., taking into account the minute
volume ventilation rate) between children and adults
was slightly larger than in the deposition fraction, with a
~20% higher rate for the children compared to the
adults. That was when sitting in a relaxed position. The
real difference in deposition rate, and thus in deposited
dose, is expected to be higher due to the generally
higher activity level, and thus breathing volume, of chil-
dren. Furthermore, the difference between adults and
children becomes larger when normalizing the deposi-
tion rates with lung surface area or body mass [27], as
was also reported by Bennett, Zeman [54].
As discussed earlier, and shown in Fig. 3, the DF for
the children is nicely predicted with the same linear
regression model as for the adults. In the study by
Bennett, Zeman [54], the best predictors of the lung de-
position for adults were Tbc and the mean effective air-
space diameter (MEAD),1 while for children, VT was a
better predictor than Tbc. We see the same trend in our
data: that VT becomes more important when including
the children in the analysis (for particles <3500 nm).
However, Tbc is still a better predictor, or as good as VT.
With the exception of children, another group ex-
pected to be sensitive to exposure to airborne particles
are individuals with diseased lungs. Lung deposition data
for this group are largely lacking, especially for sub-
micrometer sized particles that dominate particulate air
pollution by number.
Conclusions
To understand why some individuals are more suscep-
tible to airborne particles than others, we must take
into account the individual variability in the probability
of particles to deposit in the lungs. In this study we
investigate factors that determine individual variability
in the lung deposition of airborne particles, for healthy
subjects, during relaxed breathing. We find a large indi-
vidual variability in respiratory tract deposition efficiency
where subjects with high deposition of a certain particle
size in general have a high deposition for all particles – up
to particles of a diameter of 3500 nm. The individual vari-
ability is explained by two factors: breathing pattern and
lung-intrinsic properties. The most important predictors
are found to be time of a breath cycle (the inverse of
breathing frequency) and anatomical airway dead space,
followed by tidal volume and resistance of the respiratory
system (R5), measured by impulse oscillometry. We found
support for the hypothesis that pulmonary particle deposi-
tion to a large extent is determined by: (i) the residence
time of the air in the peripheral airways, and (ii) the
fraction of the tidal volume that reaches the peripheral
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airways. This hypothesis explains the correlation of Tbc
(time of a breath cycle) and Tv (tidal volume) with DF.
The fraction of the tidal volume reaching the peripheral
lungs is, apart from tidal volume, also influenced by the
anatomical dead space (VDaw), possibly explaining one
part of the (anti) correlation between DF and VDaw. Fur-
thermore, the anatomical dead space affects the particle
residence time in the peripheral lungs. R5 is the least in-
fluential variable of the four mentioned, and thus the most
uncertain. R5 is assumed to generally reflect the dimen-
sions of the airways, as is FRC.
Endnote
1MEADs were determined by analysis of total exhaled
aerosol recovery following inspiratory capacity breaths of
an aerosol with breath holds at total lung capacity (TLC)
for 0 to 10 s of 1 μm particles.
Additional file
Additional file 1: The Additional file 1 contains (i) more details on
the measured lung function parameters and (ii) supplemental tables
and figures: A schematic illustration of the set-up, a table presenting the
bivariate correlations between selected variables, a supplemental table and
figure corresponding to Table 4 and Fig. 3 in the main article including also
children, and correlation plots. Finally, a table over selected lung function
data and deposition fractions for all individuals is given. The Supplemental
Material also contains (iii) more details on the calculation of particle losses in
a tube. (DOCX 405 kb)
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